Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KKR & Co
KKR
|
+$705M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$675M |
| 3 |
Zoetis
ZTS
|
+$510M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$404M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$538M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$397M |
| 3 |
RTX Corp
RTX
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$332M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.69% |
| 2 | Technology | 9.44% |
| 3 | Healthcare | 8.03% |
| 4 | Consumer Discretionary | 7.35% |
| 5 | Communication Services | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MBTF
5001
DELISTED
MBT Financial Corporation
MBTF
| $305K | ﹤0.01% |
26,925
-47,146
| -64% | -$519K |
|
5002
Southern First Bancshares
SFST
$591M
| $303K | ﹤0.01% |
9,282
-8,899
| -49% | -$304K |
|
|
BDSI
5003
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $303K | ﹤0.01% |
159,529
-171,059
| -52% | -$330K |
|
5004
Nuveen Multi-Market Income Fund
JMM
$54.6M
| $302K | ﹤0.01% |
40,843
+27,049
| +196% | +$199K |
|
5005
Orrstown Financial Services
ORRF
$840M
| $302K | ﹤0.01% |
13,467
-11,230
| -45% | -$248K |
|
5006
ProShares Ultra Financials
UYG
$828M
| $302K | ﹤0.01% |
9,303
-3,093
| -25% | -$101K |
|
5007
eHealth
EHTH
$42.2M
| $301K | ﹤0.01% |
25,003
-38,977
| -61% | -$451K |
|
|
ITIC
5008
Investors Title Co
ITIC
$546M
| $301K | ﹤0.01% |
1,902
-2,260
| -54% | -$306K |
|
5009
ReposiTrak
TRAK
$153M
| $301K | ﹤0.01% |
24,336
-17,309
| -42% | -$238K |
|
|
VDTH
5010
DELISTED
Videocon d2h Limited
VDTH
| $301K | ﹤0.01% |
26,192
+8,377
| +47% | +$81.8K |
|
5011
Matinas BioPharma
MTNB
$1.88M
| $300K | ﹤0.01% |
+2,166
| New | +$353K |
|
5012
Tempest Therapeutics
TPST
$13.7M
| $300K | ﹤0.01% |
55
+2
| +4% | +$9.31K |
|
5013
Weyco Group
WEYS
$372M
| $300K | ﹤0.01% |
10,679
-9,502
| -47% | -$267K |
|
|
SNT
5014
Senstar Technologies
SNT
$38M
| $298K | ﹤0.01% |
39,709
+31,865
| +406% | +$211K |
|
|
MXE
5015
Mexico Equity and Income Fund
MXE
| $297K | ﹤0.01% |
27,361
+22,303
| +441% | +$215K |
|
|
CAFD
5016
DELISTED
8point3 Energy Partners LP
CAFD
| $297K | ﹤0.01% |
21,929
-27,276
| -55% | -$366K |
|
5017
Kodak
KODK
$822M
| $295K | ﹤0.01% |
25,693
-27,133
| -51% | -$371K |
|
5018
Geospace Technologies
GEOS
$94.6M
| $294K | ﹤0.01% |
18,140
-24,422
| -57% | -$463K |
|
|
EMFM
5019
DELISTED
Global X MSCI Next Emerging & Frontier ETF
EMFM
| $290K | ﹤0.01% |
14,185
-2,430
| -15% | -$48.4K |
|
|
ATHX
5020
DELISTED
Athersys, Inc. Common Stock
ATHX
| $290K | ﹤0.01% |
6,773
-3,266
| -33% | -$104K |
|
|
LUB
5021
DELISTED
Luby's Inc.
LUB
| $290K | ﹤0.01% |
93,088
-30,849
| -25% | -$111K |
|
|
BSF
5022
DELISTED
Bear State Financial, Inc.
BSF
| $290K | ﹤0.01% |
30,753
-25,275
| -45% | -$246K |
|
|
FCO
5023
DELISTED
abrdn Global Income Fund
FCO
| $288K | ﹤0.01% |
34,186
+16,739
| +96% | +$140K |
|
|
DLA
5024
DELISTED
Delta Apparel Inc.
DLA
| $288K | ﹤0.01% |
16,322
-16,812
| -51% | -$307K |
|
5025
Ascendis Pharma A/S
ASND
$16B
| $287K | ﹤0.01% |
10,236
+9,574
| +1,446% | +$242K |
|
Similar funds
Morgan Stanley's Q1 2017 Portfolio in Review
As of Q1 2017, Morgan Stanley held 6,814 positions worth $325B, up 6.5% from $306B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q1 2017 filing shows 216 new, 2,666 increased, 3,277 reduced and 152 closed positions. Its largest new stake was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M. The largest sale was St Jude Medical, an estimated $538M.
By sector, the portfolio is most concentrated in Financials at 9.7% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.
- Morgan Stanley's largest Q1 2017 buy was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M.
- Morgan Stanley added most to KKR & Co in Q1 2017, an estimated $705M increase.
- Morgan Stanley's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $397M.
- Morgan Stanley fully exited St Jude Medical in Q1 2017, selling an estimated $538M.
- Morgan Stanley's ten largest holdings make up 12% of its $325B portfolio in Q1 2017.
- Morgan Stanley opened 216 new positions and closed 152 in Q1 2017.
- Morgan Stanley's portfolio value rose 6.5% quarter-over-quarter to $325B.
Based on Morgan Stanley's 13F filing for Q1 2017, filed 12 May 2017.